Compositions for treating epithelial barrier function disorders
OwnerMalgorzata NEPELSKA, Joel DORE +3inventors
InventorsMalgorzata NEPELSKA, Joel DORE, Herve BLOTTIERE, Antonella CULTRONE, Christophe BONNY
Life of this patent
Estimating the term…
Loading patent…
OwnerMalgorzata NEPELSKA, Joel DORE +3inventors
InventorsMalgorzata NEPELSKA, Joel DORE, Herve BLOTTIERE, Antonella CULTRONE, Christophe BONNY
Estimating the term…
The present disclosure relates to novel pharmaceutical compositions comprising recombinantly engineered probiotic bacteria that can be used, inter alia, in the treatment of gastrointestinal inflammatory diseases and epithelial barrier function disorders. The probiotic bacteria preferably contain a nucleic acid encoding the heterodimeric protein of SEQ ID NO:1 and 2, or homologous sequences thereof sharing at least 80% identity with said sequences. In some embodiments, the pharmaceutical compositions described herein have particular application in the treatment or prevention of disease states associated with abnormally permeable epithelial barriers as well as inflammatory bowel diseases or disorders.
A recombinant nucleic acid encoding a heterodimeric protein comprising a first polypeptide whose amino acid sequence is SEQ ID NO:
(canceled)
(canceled)
A pharmaceutical composition comprising at least one muropeptide chosen from the group consisting of:
(canceled)
A recombinant heterodimeric protein comprising a first polypeptide whose amino acid sequence is SEQ ID NO:
Dependencies are inferred from the claim text.